CCL2 and myocardial infarction: Another study showed that the use of 3 × 106 BM-MSCs in a rat model of MI reduced the levels of CD68-positive inflammatory cells and monocyte chemotactic protein-1 (MCP-1) in the myocardium at 3 weeks; thus, the cells contributed to improved cardiac function [134].